Unmet medical needs in chronic, non-communicable inflammatory skin diseases

H Ujiie, D Rosmarin, MP Schön, S Ständer… - Frontiers in …, 2022 - frontiersin.org
An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

Ulcerated lesions of the oral mucosa: clinical and histologic review

SG Fitzpatrick, DM Cohen, AN Clark - Head and neck pathology, 2019 - Springer
Ulcerated lesions of the oral cavity have many underlying etiologic factors, most commonly
infection, immune related, traumatic, or neoplastic. A detailed patient history is critical in …

The growing incidence of bullous pemphigoid: overview and potential explanations

K Kridin, RJ Ludwig - Frontiers in medicine, 2018 - frontiersin.org
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous
diseases. BP characteristically affects the elderly and is seen mainly in patients older than …

Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series

R Abdat, RA Waldman, V de Bedout, A Czernik… - Journal of the American …, 2020 - Elsevier
Background Bullous pemphigoid (BP) is an autoimmune blistering disorder occurring mostly
in the elderly that lacks adequate treatments. Objective To describe our experience using …

Epidermolysis bullosa acquisita: the 2019 update

H Koga, C Prost-Squarcioni, H Iwata… - Frontiers in …, 2019 - frontiersin.org
Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Patients with EBA
suffer from chronic inflammation as well as blistering and scarring of the skin and mucous …

The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease

KT Amber, M Valdebran, K Kridin, SA Grando - Frontiers in Medicine, 2018 - frontiersin.org
Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant
mortality and morbidity. While historically BP has been characterized as an IgG driven …

Epidemiology of major chronic inflammatory immune-related skin diseases in 2019

E Pezzolo, L Naldi - Expert review of clinical immunology, 2020 - Taylor & Francis
Introduction:'Chronic inflammatory immune-related skin disease'(ISDs) is an umbrella term
grouping together heterogeneous entities characterized by chronic inflammation potentially …

A review comparing international guidelines for the management of bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, and epidermolysis …

PM Patel, VA Jones, TN Murray, KT Amber - American Journal of Clinical …, 2020 - Springer
Autoimmune blistering disease management can be challenging as treatment modalities
vary greatly and no single standard of care exists. We consolidated the recommendations of …

Incidence of pemphigoid diseases in Northern Germany in 2016–first data from the Schleswig‐Holstein Registry of Autoimmune Bullous Diseases

N Van Beek, A Weidinger… - Journal of the …, 2021 - Wiley Online Library
Background Autoimmune bullous diseases (AIBD) are rare disorders characterized by
autoantibody formation against components of adhesion molecules; in pemphigoid diseases …

Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita-Brazilian …

CG Santi, AC Gripp, AM Roselino, DS Mello… - Anais brasileiros de …, 2019 - SciELO Brasil
Bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita
are subepidermal autoimmune blistering diseases whose antigenic target is located at the …